Foghorn Therapeutics's market cap is currently $243.64M. The company's EPS TTM is $-0.28; its P/E ratio is ―; Foghorn Therapeutics is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
